Overuse of acid suppressive therapy in hospitalized patients

American Journal of Gastroenterology

Volumn 95, Issue 11, 2000, Pages 3118-3122

  Nardino, Robert J ^a,b,d   Vender, Ronald J ^a,b,d   Herbert, Peter N ^c,d  

^a Department of Medicine ^*  (United States)

^b HOSPITAL OF SAINT RAPHAEL   (United States)

^c YALE NEW HAVEN HOSPITAL   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIULCER AGENT; FAMOTIDINE; GASTROINTESTINAL MUCOSA PROTECTIVE AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PROTON PUMP INHIBITOR; SUCRALFATE;

ARTICLE; COMMUNITY HOSPITAL; DRUG INDICATION; DRUG UTILIZATION; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; PROPHYLAXIS; STOMACH ACID SECRETION; TEACHING HOSPITAL; THROMBOCYTOPENIA; ULCER;

ANTACIDS; ANTI-ULCER AGENTS; DRUG UTILIZATION; FEMALE; HISTAMINE H2 ANTAGONISTS; HOSPITALIZATION; HUMANS; MALE; PATIENT DISCHARGE; PEPTIC ULCER; PROTON PUMPS; STRESS;

EID: 0033755629     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)02052-9     Document Type: Article

References (22)

1. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group
2. Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses
3. Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit. A randomized, controlled, single-blind study
4. Current guidelines on stress ulcer prophylaxis
5. Evaluation of direct pharmacist intervention on conversion from parenteral to oral histamine H2-receptor antagonist therapy
6. Multi-purpose evaluation of H2-antagonist usage
7. Change in prescribing patterns of intravenous histamine2-receptor antagonists results in significant cost savings without adversely affecting patient care
8. Economic impact of inappropriate histamine2-receptor antagonist use
9. Are we correctly using the inhibitors of gastric acid secretion and cytoprotective drugs? Results of a multicentre study
10. Long term acid suppressing treatment in general practice
11. Prophylactic therapy for stress ulcer bleeding: A reappraisal
12. Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit
13. National survey of stress ulcer prophylaxis
14. Prophylaxis of gastrointestinal tract bleeding with magaldrate in patients admitted to a general hospital ward
15. Gastrointestinal bleeding in the hospitalized patient: A case-control study to assess risk factors, causes, and outcome
16. Corticosteroids and peptic ulcer: Metaanalysis of adverse events during steroid therapy
17. Corticosteroid use and peptic ulcer disease: Role of nonsteroidal anti-inflammatory drugs
18. Cimetidine in the treatment of acute alcoholic pancreatitis. A randomized, double-blind study
19. A randomized trial comparing cimetidine to nasogastric suction in acute pancreatitis
20. A clinical trial of cimetidine in acute pancreatitis
21. Impacting cost and appropriateness of stress ulcer prophylaxis at a university medical center
22. Implementation of a clinical practice guideline for stress ulcer prophylaxis increases appropriateness and decreases cost of care